These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22242849)

  • 1. Falcipain inhibition as a promising antimalarial target.
    Marco M; Coterón JM
    Curr Top Med Chem; 2012; 12(5):408-44. PubMed ID: 22242849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery.
    Bekono BD; Ntie-Kang F; Owono Owono LC; Megnassan E
    Curr Drug Targets; 2018; 19(5):501-526. PubMed ID: 28003005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine proteases of malaria parasites.
    Rosenthal PJ
    Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falcipains and other cysteine proteases of malaria parasites.
    Rosenthal PJ
    Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of whole genome sequence data on drug discovery--a malaria case study.
    Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
    Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
    Qidwai T
    Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falcipain cysteine proteases of malaria parasites: An update.
    Rosenthal PJ
    Biochim Biophys Acta Proteins Proteom; 2020 Mar; 1868(3):140362. PubMed ID: 31927030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.
    Singh A; Rosenthal PJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):949-51. PubMed ID: 11181388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.
    Teixeira C; Gomes JR; Gomes P
    Curr Med Chem; 2011; 18(10):1555-72. PubMed ID: 21428877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites.
    Sijwali PS; Kato K; Seydel KB; Gut J; Lehman J; Klemba M; Goldberg DE; Miller LH; Rosenthal PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8721-6. PubMed ID: 15166288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine proteases of malaria parasites: targets for chemotherapy.
    Rosenthal PJ; Sijwali PS; Singh A; Shenai BR
    Curr Pharm Des; 2002; 8(18):1659-72. PubMed ID: 12132997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial activities of novel synthetic cysteine protease inhibitors.
    Lee BJ; Singh A; Chiang P; Kemp SJ; Goldman EA; Weinhouse MI; Vlasuk GP; Rosenthal PJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3810-4. PubMed ID: 14638488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.
    Subramanian S; Hardt M; Choe Y; Niles RK; Johansen EB; Legac J; Gut J; Kerr ID; Craik CS; Rosenthal PJ
    PLoS One; 2009; 4(4):e5156. PubMed ID: 19357776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum.
    Sijwali PS; Koo J; Singh N; Rosenthal PJ
    Mol Biochem Parasitol; 2006 Nov; 150(1):96-106. PubMed ID: 16890302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Falcipain-2 and Falcipain-3 Inhibitors as Promising Antimalarial Agents.
    Ettari R; Previti S; Di Chio C; Zappalà M
    Curr Med Chem; 2021; 28(15):3010-3031. PubMed ID: 32744954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4.
    Melo PMS; El Chamy Maluf S; Azevedo MF; Paschoalin T; Budu A; Bagnaresi P; Henrique-Silva F; Soares-Costa A; Gazarini ML; Carmona AK
    Parasitol Int; 2018 Apr; 67(2):233-236. PubMed ID: 29288140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity.
    Rana D; Kalamuddin M; Sundriyal S; Jaiswal V; Sharma G; Das Sarma K; Sijwali PS; Mohmmed A; Malhotra P; Mahindroo N
    Bioorg Med Chem; 2020 Jan; 28(1):115155. PubMed ID: 31744777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
    Moura PA; Dame JB; Fidock DA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium falciparum: biochemical characterization of the cysteine protease falcipain-2'.
    Singh N; Sijwali PS; Pandey KC; Rosenthal PJ
    Exp Parasitol; 2006 Mar; 112(3):187-92. PubMed ID: 16337629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II.
    Jin H; Xu Z; Cui K; Zhang T; Lu W; Huang J
    Fitoterapia; 2014 Apr; 94():55-61. PubMed ID: 24468190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.